journal article·2022-01-11Open access

Do Human iPSC-Derived Cardiomyocytes Cultured on PLA Scaffolds Induce Expression of CD28/CTLA-4 by T Lymphocytes?

David Sergeevichev, Victor Balashov, Victoria Kozyreva, Sophia Pavlova, Maria Vasiliyeva, Alexander Romanov, Elena Chepeleva

Abstract

Many research groups have developed various types of tissue-engineered cardiac constructs. However, the immunological properties of such artificial tissues are not yet fully understood. Previously, we developed microfiber scaffolds carrying human iPSC-derived cardiomyocytes (hiPSC-CM). In this work, we evaluated the ability of these tissue-engineered constructs to activate the expression of CD28 and CTLA-4 proteins on T lymphocytes, which are early markers of the immune response. For this purpose, electrospun PLA microfiber scaffolds were seeded with hiPSC-CM and cultured for 2 weeks. Allogeneic mononuclear cells were then co-cultured for 48 h with three groups of samples: bare scaffolds, pure cardiomyocyte culture and tissue-engineered constructs, followed by analysis of CD28/CTLA-4 expression on T lymphocytes using flow cytometry. PLA scaffolds and concanavalin A stimulation (positive control) statistically significantly increased CD28 expression on CD4+ T cells (up to 61.3% and 66.3%) CD8+ T cells (up to 17.8% and 21.7%). CD28/CTLA-4 expression was not increased when T lymphocytes were co-cultured with cardiac tissue-engineered constructs and iPSC-CM monolayers. Thus, iPSC-CM in monolayers and on PLA microfiber scaffolds did not induce T cell activation, which suggests that such cardiac constructs would not be a cause of rejection after implantation.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · 3D Printing in Biomedical Research · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

E. Meshalkin National Medical Research Center, The Ministry of Health of the Russian Federation, 15, Rechkunovskaya Str., 630055 Novosibirsk, Russia

Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 3, Institutskaya Str., Puschino, 142290 Moscow, Russia

Federal Research Center Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, 10, Ac. Lavrentiev Ave., 630090 Novosibirsk, Russia

Zelman Institute for the Medicine and Psychology, The Novosibirsk State University, 1, Pirogov Str., 630090 Novosibirsk, Russia

Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, 2, Timakova Str., 630060 Novosibirsk, Russia

Funding

Ministry of Health of Russian Federation

References (47)

Show source-provided references
1. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research10.4239/wjd.v6.i13.1246 ↗
2. Systemic delivery of bone marrow–derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution10.1161/01.CIR.0000084828.50310.6A ↗
3. Current research trends and challenges in tissue engineering for mending broken hearts10.1016/j.lfs.2019.05.012 ↗
4. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors10.1016/j.cell.2006.07.024 ↗
5. Differentiation of pluripotent embryonic stem cells into cardiomyocytes10.1161/01.RES.0000027865.61704.32 ↗
6. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions10.1038/nprot.2012.150 ↗
7. Implantation of sinoatrial node cells into canine right ventricle: Biological pacing appears limited by the substrate10.3727/096368911X565038b ↗
8. Polyglycolic acid-polylactic acid scaffold response to different progenitor cell in vitro cultures: A demonstrative and comparative X-ray synchrotron radiation phase-contrast microtomography study10.1089/ten.tec.2013.0213 ↗
9. Designing of PLA scaffolds for bone tissue replacement fabricated by ordinary commercial 3D printer10.1186/s13036-017-0074-3 ↗
10. Electrospun conducting and biocompatible uniaxial and Core–Shell fibers having poly(lactic acid), poly(ethylene glycol), and polyaniline for cardiac tissue engineering10.1021/acsomega.8b03411 ↗
11. Electrospun nanofiber scaffolds: Engineering soft tissues10.1088/1748-6041/3/3/034002 ↗
12. Polymer-based platforms by electric field-assisted techniques for tissue engineering and cancer therapy10.1586/17434440.2014.953058 ↗
13. Analyis of biological compatibility of polylactide nanofibrous matrix vitalized with cardiac fibroblasts in a porcine model10.23868/201707031 ↗
14. Relative frequencies of alloantigen-specific helper CD4 T cells and B cells determine mode of antibody-mediated allograft rejection10.3389/fimmu.2018.03039 ↗
15. Decellularization as a way to prevent activation of the immune response to allogeneic pulmonary heart valves
16. Selective CD28 Inhibition Modulates Alloimmunity and Cardiac Allograft Vasculopathy in Anti–CD154-Treated Monkeys10.1097/TP.0000000000002044 ↗
17. Grigor’eva, E., Malankhanova, T., Surumbayeva, A., Minina, J., Kizilova, E., Lebedev, I., and Zakian, S. (2018). Generation and characterization of iPSCs from human embryonic dermal fibroblasts of a healthy donor from Siberian population. BioRxiv, 455535.10.1101/455535 ↗
18. Chemically defined generation of human cardiomyocytes10.1038/nmeth.2999 ↗
19. High resolution 3D microscopy study of cardiomyocytes on polymer scaffold nanofibers reveals formation of unusual sheathed structure10.1016/j.actbio.2017.12.031 ↗
20. Parrotta, E., Lucchino, V., Scaramuzzino, L., Scalise, S., and Cuda, G. (2020). Modeling cardiac disease mechanisms using induced pluripotent stem cell-derived cardiomyocytes: Progress, promises and challenges. Int. J. Mol. Sci., 21.10.3390/ijms21124354 ↗
21. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes10.1016/j.stem.2012.09.013 ↗
22. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement10.1096/fasebj.14.5.669 ↗
23. Extracellular matrix, mechanotransduction and structural hierarchies in heart tissue engineering10.1098/rstb.2007.2114 ↗
24. Fiber alignment and coculture with fibroblasts improves the differentiated phenotype of murine embryonic stem cell-derived cardiomyocytes for cardiac tissue engineering10.1002/bit.23353 ↗
25. Modulation of alignment, elongation and contraction of cardiomyocytes through a combination of nanotopography and rigidity of substrates10.1016/j.actbio.2011.05.021 ↗
26. Engineering aligned human cardiac muscle using developmentally inspired fibronectin micropatterns10.1038/s41598-021-87550-y ↗
27. Pekkanen-Mattila, M., Häkli, M., Pölönen, R.-P., Mansikkala, T., and Junnila, A. (2019). Polyethylene Terephthalate Textiles Enhance the Structural Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Materials, 12.10.3390/ma12111805 ↗
28. Recent advances in stem cell therapeutics and tissue engineering strategies10.1186/s40824-018-0148-4 ↗
29. Induced pluripotent stem cells: Problems and advantages when applying them in regenerative medicine10.32607/20758251-2010-2-2-18-27 ↗
30. Antibody-mediated rejection of solid-organ allografts10.1056/NEJMra1802677 ↗
31. Gilani, S., Vuga, L., Lindell, K., Gibson, K., and Xue, J. (2010). CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS ONE, 5.10.1371/journal.pone.0008959 ↗
32. Dilek, N., Poirier, N., Hulin, P., Coulon, F., and Mary, C. (2013). Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells. PLoS ONE, 8.10.1371/journal.pone.0083139 ↗
33. Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family10.1016/j.immuni.2016.05.002 ↗
34. CD8(+)CD28(+)/CD8(+)CD28(−) T cell equilibrium can predict the active stage for patients with inflammatory bowel disease10.1016/j.clinre.2017.03.009 ↗
35. Altered expression of T lymphocyte surface markers in children with chronic autoimmune thyroiditis
36. CD86 is a selective CD28 ligand supporting FoxP3+ regulatory T cell homeostasis in the presence of high levels of CTLA-410.3389/fimmu.2020.600000 ↗
37. Revealing the atomistic details behind the binding of B7-1 to CD28 and CTLA-4: A comprehensive protein-protein modelling study10.1016/j.bbagen.2018.08.010 ↗
38. HLA and Histo-blood group antigen expression in human pluripotent stem cells and their derivatives10.1038/s41598-017-12231-8 ↗
39. The detailed distribution of MHC Class II antigens in normal human organs10.1097/00007890-198409000-00019 ↗
40. Expression of class I and class II major histocompatibility antigens in normal and transplanted human heart10.1097/00007890-198606000-00021 ↗
41. The immune system10.1056/NEJM200007063430107 ↗
42. Cardiomyocytes derived from MHC-homozygous induced pluripotent stem cells exhibit reduced allogeneic immunogenicity in MHC-matched non-human primates10.1016/j.stemcr.2016.01.012 ↗
43. Syngeneic mesenchymal stem cells reduce immune rejection after induced pluripotent stem cell-derived allogeneic cardiomyocyte transplantation10.1038/s41598-020-58126-z ↗
44. Donor-specific anti-HLA antibody production following pediatric ABO-incompatible heart transplantation10.1111/petr.13332 ↗
45. Transplant rejections associated with immune checkpoint inhibitors: A pharmacovigilance study and systematic literature review10.1016/j.ejca.2021.01.038 ↗
46. Immunosuppression and adult heart transplantation: Emerging therapies and opportunities10.1080/14779072.2017.1267565 ↗
47. Engineering Myocardium for Heart Regeneration—Advancements, Considerations, and Future Directions10.3389/fcvm.2020.586261 ↗